Neurodegenerative diseases represent some of today’s most devastating diseases afflicting man. With an aging population, thanks to improved medicine and healthcare, the incidence of diseases such as Alzheimer’s disease, Multiple Sclerosis (MS), Parkinson’s disease and other neurodegenerative disorders is increasing, and is taking a significant toll on patients, their families and caregivers, health care providers and worldwide economies. For example, MS alone affects about 2.5 million people worldwide and it is not considered a fatal disease, since the vast majority of patients live to a normal life span. Few therapies exist which modify the progression of the disease. This meeting brings together key thought leaders from the field of neurodegeneration research to share their latest findings and to highlight therapeutic opportunities that may reduce or even reverse the devastating effects of neurodegenerative diseases.
CANTELLI FORTI G., TOFFANO G. (2006). Molecular Approaches to Neuronal Regeneration: Opportunities in Neurodegenerative Diseases, Bologna, 27 Ottobre 2006, Oratorio San Filippo Neri, Via Manzoni 5.
Molecular Approaches to Neuronal Regeneration: Opportunities in Neurodegenerative Diseases, Bologna, 27 Ottobre 2006, Oratorio San Filippo Neri, Via Manzoni 5
CANTELLI FORTI, GIORGIO;TOFFANO, GINO
2006
Abstract
Neurodegenerative diseases represent some of today’s most devastating diseases afflicting man. With an aging population, thanks to improved medicine and healthcare, the incidence of diseases such as Alzheimer’s disease, Multiple Sclerosis (MS), Parkinson’s disease and other neurodegenerative disorders is increasing, and is taking a significant toll on patients, their families and caregivers, health care providers and worldwide economies. For example, MS alone affects about 2.5 million people worldwide and it is not considered a fatal disease, since the vast majority of patients live to a normal life span. Few therapies exist which modify the progression of the disease. This meeting brings together key thought leaders from the field of neurodegeneration research to share their latest findings and to highlight therapeutic opportunities that may reduce or even reverse the devastating effects of neurodegenerative diseases.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.